Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Context drops bispecific T-cell engager on cost-cutting initiative | PharmaVoice

Pharma Tech

Context drops bispecific T-cell engager on cost-cutting initiative

Aug 7, 2026, 10:05 AM

Read Full Article → Context drops bispecific T-cell engager on cost-cutting initiative

Context drops bispecific T-cell engager on cost-cutting initiative

Translate article text

Choose a language and wait for the translated text.

Following the discontinuation of CT-95, Context will now focus on the two other BiTEs in its pipeline, CTIM-76 and CT-202.